SCOPUS 정보 검색 플랫폼

Journal of Hepatology

Volumn 54, Issue 1, 2011, Pages 182-183

Inhibition of mammalian target of rapamycin: Two goals with one shot?

(2) Soll, Christopher a Clavien, Pierre Alain a

a UNIVERSITY HOSPITAL ZURICH (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE REGISTRY; DRUG ACTIVITY; DRUG EFFECT; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; RISK REDUCTION; SURVIVAL RATE; T LYMPHOCYTE; TUMOR CLASSIFICATION;

EID: 78649631536 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/j.jhep.2010.07.049 Document Type: Note

Times cited : (9)

References (10)

1
- 28844506738
- Will all liver transplantation patients eventually die from cancer?
- W. Sanchez, J.A. Talwalkar, and G.J. Gores Will all liver transplantation patients eventually die from cancer? J Hepatol 44 1 2006 13 18
- (2006) J Hepatol , vol.44 , Issue.1 , pp. 13-18
- Sanchez, W.¹ Talwalkar, J.A.² Gores, G.J.³

2
- 57749191711
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis
- V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 1 2009 35 43
- (2009) Lancet Oncol , vol.10 , Issue.1 , pp. 35-43
- Mazzaferro, V.¹ Llovet, J.M.² Miceli, R.³ Bhoori, S.⁴ Schiavo, M.⁵ Mariani, L.⁶

3
- 24344486114
- How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
- M. Schwartz, S. Roayaie, and J. Llovet How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 43 4 2005 584 589
- (2005) J Hepatol , vol.43 , Issue.4 , pp. 584-589
- Schwartz, M.¹ Roayaie, S.² Llovet, J.³

4
- 0032920252
- Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation
- H.J. Schlitt, M. Neipp, A. Weimann, K.J. Oldhafer, E. Schmoll, and K. Boeker Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation J Clin Oncol 17 1 1999 324 331
- (1999) J Clin Oncol , vol.17 , Issue.1 , pp. 324-331
- Schlitt, H.J.¹ Neipp, M.² Weimann, A.³ Oldhafer, K.J.⁴ Schmoll, E.⁵ Boeker, K.⁶

5
- 59649130340
- The role of mTOR inhibitors in the management of posttransplant malignancy
- A.P. Monaco The role of mTOR inhibitors in the management of posttransplant malignancy Transplantation 87 2 2009 157 163
- (2009) Transplantation , vol.87 , Issue.2 , pp. 157-163
- Monaco, A.P.¹

6
- 65349159281
- Immunoregulatory functions of mTOR inhibition
- A.W. Thomson, H.R. Turnquist, and G. Raimondi Immunoregulatory functions of mTOR inhibition Nat Rev Immunol 9 5 2009 324 337
- (2009) Nat Rev Immunol , vol.9 , Issue.5 , pp. 324-337
- Thomson, A.W.¹ Turnquist, H.R.² Raimondi, G.³

7
- 57349087153
- Pivotal role of mTOR signaling in hepatocellular carcinoma
- A. Villanueva, D.Y. Chiang, P. Newell, J. Peix, S. Thung, and C. Alsinet Pivotal role of mTOR signaling in hepatocellular carcinoma Gastroenterology 135 6 2008 1972 1983 [1983:e1971-1911]
- (2008) Gastroenterology , vol.135 , Issue.6 , pp. 1972-1983
- Villanueva, A.¹ Chiang, D.Y.² Newell, P.³ Peix, J.⁴ Thung, S.⁵ Alsinet, C.⁶

8
- 77950614403
- Serotonin promotes tumor growth in human hepatocellular cancer
- C. Soll, J.H. Jang, M.O. Riener, W. Moritz, P.J. Wild, and R. Graf Serotonin promotes tumor growth in human hepatocellular cancer Hepatology (Baltimore, Md) 51 4 2010 1244 1254
- (2010) Hepatology (Baltimore, Md) , vol.51 , Issue.4 , pp. 1244-1254
- Soll, C.¹ Jang, J.H.² Riener, M.O.³ Moritz, W.⁴ Wild, P.J.⁵ Graf, R.⁶

9
- 43849095466
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
- M.A. Zimmerman, J.F. Trotter, M. Wachs, T. Bak, J. Campsen, and A. Skibba Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma Liver transpl 14 5 2008 633 638
- (2008) Liver Transpl , vol.14 , Issue.5 , pp. 633-638
- Zimmerman, M.A.¹ Trotter, J.F.² Wachs, M.³ Bak, T.⁴ Campsen, J.⁵ Skibba, A.⁶

10
- 77950624678
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- C. Toso, S. Merani, D.L. Bigam, A.M. Shapiro, and N.M. Kneteman Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma Hepatology (Baltimore, Md) 51 4 2010 1237 1243
- (2010) Hepatology (Baltimore, Md) , vol.51 , Issue.4 , pp. 1237-1243
- Toso, C.¹ Merani, S.² Bigam, D.L.³ Shapiro, A.M.⁴ Kneteman, N.M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.